SJS Investment Consulting’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.24K Buy
118
+2
+2% +$60 ﹤0.01% 1971
2026
Q2
$3.43K Buy
+116
New +$2.98K ﹤0.01% 1547
2024
Q4
– Sell
-17
Closed -$1.08K – 1601
2024
Q3
$1.08K Buy
17
+2
+13% +$144 ﹤0.01% 1043
2024
Q2
$1.01K Sell
15
-12
-44% -$838 ﹤0.01% 1020
2024
Q1
$2.14K Buy
27
+1
+4% +$82 ﹤0.01% 717
2023
Q4
$2.02K Buy
26
+6
+30% +$444 ﹤0.01% 661
2023
Q3
$1.41K Sell
20
-1
-5% -$75 ﹤0.01% 781
2023
Q2
$1.67K Buy
21
+12
+133% +$867 ﹤0.01% 672
2023
Q1
$651 Sell
9
-19
-68% -$1.48K ﹤0.01% 1053
2022
Q4
$2.3K Buy
28
+6
+27% +$495 ﹤0.01% 575
2022
Q3
$1K Buy
+22
New +$1.76K ﹤0.01% 579
2022
Q1
$0 Buy
+3
New +$174 ﹤0.01% 663

Other funds holding ACHC

SJS Investment Consulting's ACHC Position: Q3 2026 in Review

SJS Investment Consulting increased its Acadia Healthcare (ACHC) stake by 1.7% in Q3 2026, buying an estimated $60 and bringing the position to 118 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

SJS Investment Consulting first reported a position in ACHC in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.43K in Q2 2026. 158 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

  • SJS Investment Consulting held 118 shares of Acadia Healthcare worth $3.24K as of Q3 2026.
  • SJS Investment Consulting bought 2 Acadia Healthcare shares in Q3 2026, an estimated $60.
  • Acadia Healthcare made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1971 holding.
  • SJS Investment Consulting first reported a position in Acadia Healthcare in Q1 2022 and has held it in 12 quarters since.
  • SJS Investment Consulting's Acadia Healthcare position peaked at $3.43K in Q2 2026.
  • 158 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.